IMS Company Profiles - Report Buyer

IMS COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING
Postal Ad dress: PO Box 1076, Ja karta 10010
Street Ad dress: 35th Floor WISMA 46 - KOTA
BNI, Jl. Jenderal Sudirman Kav. 1, Ja karta 10220
Tel: +62 21 2513251
Fax: +62 21 2513252
Home Page: www.id.novartis.com
De scrip tion: De vel oper, man u fac turer, for mu la -
tor, packager/as sem bler, im porter, ex porter, pro -
moter, sales/detailer. Man u fac tures for other
com pa nies. Prod uct ranges in clude: phar ma ceu ti -
cal prod ucts (branded, pre scrip tion, non-pre scrip -
tion), hos pi tal pharmaceuticals, raw materials.
Established 1985.
Con tacts (Pharm): Chair man: Dr Wil liam
Biantoro Wanandi; Com mer cial Op er a tions: Indra
Santana; Man u fac ture: Indra Santana
Sub sid iary of: Novartis, Swit zer land (100%)
Phar ma ceu ti cal Sales: US$ 35-40 mil lion
Prod ucts (% of Sales by Lead ing 5): 40-45%
Ther a peu tic Classes (% of Sales by Lead ing
5): 50-55%
Dose Forms (% of Sales by Lead ing 5):
85-90%
Prin ci pal Prod ucts:
DIOVAN (an gio ten sin-II an tag o nist plain)
VOLTAREN (antirheumatic non-steroidal;
antirheumatic top i cal)
CATAFLAM (antirheumatic non-steroidal)
SYNTOCINON (la bor in ducer)
CLOZARIL (antipsychotic)
Ther a peu tic Range:
renin-an gio ten sin sys tem agents 20%
anti rheu ma tics sys temic 17%
gynecologicals other 6%
anti rheu ma tics top i cal 5%
na sal prep a ra tions 5%
Lead ing Dose Forms:
tab lets 32%
coated tab lets 20%
cap sules 17%
liq uids 11%
am poules 8%
SANDOZ
Full Name: PT. Sandoz In do ne sia
Street Ad dress: Menara Jamsostek, South
Tower 24th Floor, Jl. Gatot Subroto No. 38, Ja -
karta 12710
Tel: +62 21 5290 1777
Fax: +62 21 5290 1773
Home Page: www.id.novartis.com
Phar ma ceu ti cal Sales: US$ 18-20 mil lion
Prod ucts (% of Sales by Lead ing 5): 40-45%
Ther a peu tic Classes (% of Sales by Lead ing
5): 75-80%
Dose Forms (% of Sales by Lead ing 5):
95-100%
Prin ci pal Prod ucts:
OSPAMOX (pen i cil lin broad spec trum)
AMDIXAL (cal cium an tag o nist plain)
RIMSTAR 4 FDC (antitubercular prod uct)
TONAR (al i men tary tract/me tab o lism prod uct
other)
ATORSAN (cho les terol/triglyceride reg u lat ing
prep a ra tion)
Ther a peu tic Range:
antimycobacterials 26%
antibacterials sys temic 26%
lipid-reg u lat ing/antiatheroma prep a ra tions
10%
cal cium an tag o nists 9%
al i men tary tract and me tab o lism prod ucts other
7%
Lead ing Dose Forms:
coated tab lets 40%
tab lets 35%
cap sules 15%
liq uids 4%
vi als 4%
IRELAND
NOVARTIS
Full Name: Novartis Ire land Ltd
Street Ad dress: Beech House, Beech Hill Of fice
Cam pus, Clonskeagh, Dub lin 4
Tel: +353 1 2601255
Fax: +353 1 2601263
Email: info.dub lin@pharma.novartis.com
Home Page: www.ie.novartis.com
De scrip tion: Re searcher, im porter, dis trib u tor,
pro moter, sales/detailer. Prod uct ranges in clude:
phar ma ceu ti cal prod ucts (branded, pre scrip tion,
non-pre scrip tion), hos pi tal pharmaceuticals, di -
ag nos tic prod ucts, bio tech nol ogy prod ucts, oph -
thal mic prod ucts, op ti cal in stru ments, vet er i nary
pharmaceuticals. Es tab lished 1997. Di vi sions
include: Novartis Consumer Health.
Con tacts (Pharm): Com mer cial Op er a tions:
Klaus Ribbe; Man u fac ture: F. Sutter; Mar ket Re -
search: L. Callaghan; Re search & De vel op ment:
O. Ros
Sub sid iary of: Novartis, Swit zer land (100%)
Phar ma ceu ti cal Sales: US$ 55-60 mil lion
© 2009 IMS Health In cor po rated or its af fil i ates Page 178